Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 12 2021
21 12 2021
Historique:
received:
04
09
2021
accepted:
09
12
2021
entrez:
22
12
2021
pubmed:
23
12
2021
medline:
1
2
2022
Statut:
epublish
Résumé
The Na
Identifiants
pubmed: 34934125
doi: 10.1038/s41598-021-03722-w
pii: 10.1038/s41598-021-03722-w
pmc: PMC8692498
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Antidepressive Agents
0
Quinazolines
0
Sodium-Hydrogen Exchanger 1
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
24380Informations de copyright
© 2021. The Author(s).
Références
Pedersen, S. F. & Counillon, L. The SLC9A-C mammalian Na+/H+ exchanger family: molecules, mechanisms, and physiology. Physiol. Rev. 99, 2015–2113 (2019).
pubmed: 31507243
doi: 10.1152/physrev.00028.2018
Karmazyn, M. NHE-1: still a viable therapeutic target. J. Mol. Cell. Cardiol. 61, 77–82 (2013).
pubmed: 23429008
doi: 10.1016/j.yjmcc.2013.02.006
Shi, Y., Kim, D., Caldwell, M. & Sun, D. The role of Na(+)/h(+) exchanger isoform 1 in inflammatory responses: maintaining H(+) homeostasis of immune cells. Adv. Exp. Med. Biol. 961, 411–418 (2013).
pubmed: 23224899
doi: 10.1007/978-1-4614-4756-6_35
De Vito, P. The sodium/hydrogen exchanger: a possible mediator of immunity. Cell. Immunol. 240, 69–85 (2006).
pubmed: 16930575
doi: 10.1016/j.cellimm.2006.07.001
Liu, Y. et al. Activation of microglia depends on Na+/H+ exchange-mediated H+ homeostasis. J. Neurosci. 30, 15210–15220 (2010).
pubmed: 21068326
pmcid: 3010222
doi: 10.1523/JNEUROSCI.3950-10.2010
Zhang, Y. et al. Amelioration of Lipopolysaccharide-Induced Acute Lung Injury in Rats by Na-H Exchanger-1 Inhibitor Amiloride Is Associated with Reversal of ERK Mitogen-Activated Protein Kinase. BioMed Res. Int. 2018, 1–7 (2018).
Ali, A., Ahmad, F. J., Pillai, K. K. & Vohora, D. Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy. Behav. 5, 322–328 (2004).
pubmed: 15145301
doi: 10.1016/j.yebeh.2004.01.005
Gumina, R. J., Newman, P. J. & Gross, G. J. Effect on ex vivo platelet aggregation and in vivo cyclic flow with Na+/H+ exchange inhibition: Gumina, NHE-1 inhibition and platelet aggregation. J. Thromb. Thrombolysis 31, 431–435 (2011).
pubmed: 21082215
pmcid: 3096849
doi: 10.1007/s11239-010-0530-0
Lee, K.-S. et al. Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor. Pharmacol. Res. 53, 265–270 (2006).
pubmed: 16420980
doi: 10.1016/j.phrs.2005.12.003
Spasov, A. A. et al. Effect of NHE-1 inhibitors zoniporide and RU-1355 on the hemorheological properties of blood under conditions of brain ischemia in rats. Eksp. Klin. Farmakol. 80, 3–7 (2017).
Avila, M. Y., Seidler, R. W., Stone, R. A. & Civan, M. M. Inhibitors of NHE-1 Na+/H+ exchange reduce mouse intraocular pressure. Invest. Ophthalmol. Vis. Sci. 43, 1897–1902 (2002).
pubmed: 12036996
Lupachyk, S. et al. Na +/H +-exchanger-1 inhibition counteracts diabetic cataract formation and retinal oxidative-nitrative stress and apoptosis. Int. J. Mol. Med. 29, 989–998 (2012).
pubmed: 22407349
pmcid: 3375174
Dreffs, A., Henderson, D., Dmitriev, A. V., Antonetti, D. A. & Linsenmeier, R. A. Retinal pH and acid regulation during metabolic acidosis. Curr. Eye Res. 43, 902–912 (2018).
pubmed: 29641914
pmcid: 6095710
doi: 10.1080/02713683.2018.1458882
Wu, S. et al. Involvement of Na+/H+ exchanger 1 in advanced glycation end products-induced proliferation of vascular smooth muscle cell. Biochem. Biophys. Res. Commun. 375, 384–389 (2008).
pubmed: 18703017
doi: 10.1016/j.bbrc.2008.08.008
Sączewski, F. & Balewski, Ł. Biological activities of guanidine compounds, 2008–2012 update. Expert Opin. Ther. Pat. 23, 965–995 (2013).
pubmed: 23617396
doi: 10.1517/13543776.2013.788645
Jin, L. et al. Synthesis and Na+/H+ exchanger inhibitory activity of benzoylguanidine derivatives. Eur. J. Med. Chem. 46, 4107–4116 (2011).
pubmed: 21724305
doi: 10.1016/j.ejmech.2011.06.011
Tang, W. et al. Synthesis of a sodium-hydrogen exchange type 1 Inhibitor: an efficient Cu-catalyzed conjugated addition of a grignard reagent to an acetyl pyridinium salt. Org. Process Res. Dev. 17, 382–389 (2013).
doi: 10.1021/op300331b
Lee, S. et al. (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the Inhibition of Na+/H+ exchanger isoform-1. J. Med. Chem. 48, 2882–2891 (2005).
pubmed: 15828827
doi: 10.1021/jm0492305
Dong, Y. et al. Structure and mechanism of the human NHE1-CHP1 complex. Nat. Commun. 12, 3474 (2021).
pubmed: 34108458
pmcid: 8190280
doi: 10.1038/s41467-021-23496-z
Hameed, A. et al. Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016). Expert Opin. Ther. Pat. 28, 281–297 (2018).
pubmed: 29368977
doi: 10.1080/13543776.2018.1432596
Gupta, T. et al. Current perspectives on quinazolines with potent biological activities: a review. Synth. Commun. 48, 1099–1127 (2018).
doi: 10.1080/00397911.2018.1431282
Das, R., Mehta, D. K. & Dhanawat, M. Bestowal of quinazoline Scaffold in anticancer drug discovery. Anticancer Agents Med. Chem. 21, 1350–1368 (2021).
pubmed: 32593282
doi: 10.2174/1871520620666200627205321
Asif, M. Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives. Int. J. Med. Chem. 2014, 395637 (2014).
pubmed: 25692041
pmcid: 4321853
Ozerov, A. et al. Pyrimidine derivatives of N-acetylguanidine: novel inhibitors of sodium-hydrogen exchanger 1. Heterocycles 96, 1101 (2018).
doi: 10.3987/COM-18-13904
Petrov, V. I. et al. Derivatives of quinazolin-4(3h)-one inhibiting sodium-hydrogen exchange. RU2654062C2 (2018).
Wang, W., Sasaki, H., Chien, D. S. & Lee, V. H. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr. Eye Res. 10, 571–579 (1991).
pubmed: 1680041
doi: 10.3109/02713689109001766
Kidron, H., Vellonen, K.-S., del Amo, E. M., Tissari, A. & Urtti, A. Prediction of the corneal permeability of drug-like compounds. Pharm. Res. 27, 1398–1407 (2010).
pubmed: 20387098
doi: 10.1007/s11095-010-0132-8
Nagai, R., Murray, D. B., Metz, T. O. & Baynes, J. W. Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 61, 549–559 (2012).
pubmed: 22354928
pmcid: 3282805
doi: 10.2337/db11-1120
Hauh-Jyun, C. C. & Cerami, A. Mechanism of inhibition of advanced glycosylation by aminoguanidine in Vitro. J. Carbohydr. Chem. 12, 731–742 (1993).
doi: 10.1080/07328309308019003
Litvinov, R., Usmiyanova, L. E., Klimenko, D. R. & Gontareva, A. V. Paradoxal activity of aminoguanidine in the model of glycoxidation with copper cations. J. Volgogr. State Med. Univ. 75, 159–165 (2020).
doi: 10.19163/1994-9480-2020-3(75)-159-165
Lal, B. et al. Tricyclic guanidine derivatives as sodium-proton exchange inhibitors. WO2006051476 (2006).
Spasov, A. A., Gurova, N. A. & Kharitonova, M. V. Structure and physiological role of NHE1 and pharmacological regulation of its activity. Eksp. Klin. Farmakol. 76, 43–48 (2013).
pubmed: 23461016
Gurova, N. A., Spasov, A. A., Timofeeva, A. S., Zheltova, A. A. & Fedorchuk, V. I. Cardioprotective properties of zoniporide studied on experimental ischemia and reperfusion models in rat myocardium. Eksp. Klin. Farmakol. 76, 17–19 (2013).
pubmed: 24228483
Spasov, A. A. et al. Neuroprotective properties of a new inhibitor of Na+/H+ exchanger (compound RU-1355) on the model of focal ischemia in rats. Eksp. Klin. Farmakol. 79, 3–7 (2016).
pubmed: 29949696
Spasov, A. A., Gurova, N. A., Timofeeva, A. S. & Sorokin, S. M. Experimental study of the antiarrhythmic properties of zoniporide. Eksp. Klin. Farmakol. 77, 13–17 (2014).
pubmed: 25102729
Mao, D. et al. Synthesis and Na(+)/H(+) exchanger-1 inhibitory activity of substituted (quinolinecarbonyl)guanidine derivatives. Chem. Biodivers. 6, 1727–1736 (2009).
pubmed: 19842138
doi: 10.1002/cbdv.200800268
Lee, S., Yi, K. Y., Youn, S. J., Lee, B. H. & Yoo, S. (2-Aryl-5-methylimidazol-4-ylcarbonyl)guanidines and (2-aryl-5-methyloxazol-4-ylcarbonyl)guanidines as NHE-1 inhibitors. Bioorg. Med. Chem. Lett. 19, 1329–1331 (2009).
pubmed: 19201189
doi: 10.1016/j.bmcl.2009.01.060
du Sert, N. P. et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 20. PLOS Biol. 18, e3000411 (2020).
doi: 10.1371/journal.pbio.3000411
Kusumoto, K. et al. In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559. Br. J. Pharmacol. 135, 1995–2003 (2002).
pubmed: 11959803
pmcid: 1573312
doi: 10.1038/sj.bjp.0704647
Rosskopf, D. Sodium-hydrogen exchange and platelet function. J. Thromb. Thrombolysis 8, 15–24 (1999).
pubmed: 10481210
doi: 10.1023/A:1008986329267
Vassiliev, P. M. et al. Consensus Drug Design Using IT Microcosm. In Application of Computational Techniques in Pharmacy and Medicine 17, 369–431 (2014).
doi: 10.1007/978-94-017-9257-8_12
Hilbe, J. M. Statistica 7. Am. Stat. 61, 91–94 (2007).
doi: 10.1198/000313007X172998
Anisimova, V. A. et al. Synthesis and pharmacological activity of 3-(2,2,2-trichloro-1- hydroxyethyl)imidazo [1, 2-a]benzimidazole dihydrochlorides. Pharm. Chem. J. 43, 491–494 (2009).
doi: 10.1007/s11094-009-0340-x
Pease, M. E., Hammond, J. C., Quigley, H. A. Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice. J. Glaucoma 15, 512–519 (2006).
pubmed: 17106364
doi: 10.1097/01.ijg.0000212276.57853.19
Marcus, A. J. et al. Data on the effects of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on intraocular pressure of ocular normotensive rats. Data Brief 18, 523–554 (2018).
pubmed: 29896529
pmcid: 5996230
doi: 10.1016/j.dib.2018.03.019
Steru, L., Chermat, R., Thierry, B. & Simon, P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85, 367–370 (1985).
pubmed: 3923523
doi: 10.1007/BF00428203